Glenmark Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has issued a postal ballot notice seeking shareholder approval for the appointment of Mr. Anurag Mantri (DIN: 05326463) as Whole-time Director, designated as Executive Director & Global CFO, for a 5-year term from May 27, 2025 to May 26, 2030. Mr. Mantri is a qualified Chartered Accountant with over three decades of experience, previously serving as Executive Director & Group CFO at Jindal Stainless Limited, and holding senior roles at HCL Tech, SRF, Cairn, Schneider Electric, and L&T. His proposed annual compensation includes a salary of ₹1.68 crore, personal pay of ₹2.58 crore, plus perquisites and long-term incentives ranging from ₹1 crore (FY26) to ₹2 crore (FY28), with up to 30% annual increments thereafter. The e-voting window is open from July 3, 2025 to August 1, 2025, with results to be announced by August 5, 2025.
This is a routine governance matter seeking shareholder ratification of a senior leadership appointment already effective since May 2025. The total annual compensation package is significant, but the appointment of an experienced CFO from a leading listed company signals continuity in financial leadership. Shareholders should review the remuneration details and exercise their voting rights before the August 1, 2025 deadline.